As an FDA-approved GLP-1 receptor agonist, semaglutide is marketed under brand names such as Wegovy, specifically for weight management, and Ozempic, for type 2 diabetes
The test does not predict response to tirzepatide or any specific compound
Opioid Use Disorder: Semaglutide May Reduce Opioid Overdose Participants with Type 2 diabetes and opioid use disorder taking semaglutide were about 60% less likely to overdose compared to those taking other diabetes drugs, according to new research
Rev Endocr Metab Disord 23(3):521539 Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Mller DV, Treppendahl MB, Verma S et al (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes
ABCG2 dysfunction enhances UA level and promotes renal dysfunction in CKD patients as well as systemic inflammatory responses (Bhatnagar et al., 2016